Selective Mitochondrial Uncoupler for Fat Loss and Muscle Preservation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for weight loss often result in the loss of skeletal muscle mass, which can lead to increased risks of complications and a decrease in quality of life, especially in obese individuals. Additionally, existing mitochondrial uncouplers like 2,4-dinitrophenol are associated with severe adverse effects, making them unsafe for human consumption.
Innovation Solution
The use of 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1H-imidazole, a novel small molecule uncoupler, to promote controlled metabolic acceleration, thereby reducing fat accumulation while preserving skeletal muscle mass during weight loss.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If 2,4-dinitrophenol is used as a mitochondrial uncoupler for weight loss, then fat oxidation is enhanced, but severe adverse effects occur including hyperthermia, tachycardia, and death
Solution Approach 1:
The patent modifies the chemical structure of DNP by replacing nitro groups with less toxic substituents (halogens, alkyl groups, etc.) to reduce toxicity while maintaining the mitochondrial uncoupling effect. This structural parameter change allows the compound to selectively uncouple mitochondria in adipose tissue without causing systemic toxicity
Solution Approach 2:
The patent designs uncouplers with selective tissue distribution, targeting adipose tissue specifically while sparing muscle tissue. This is achieved through molecular design that favors accumulation in fat cells, allowing localized fat oxidation without systemic adverse effects on other organs
2Quantity of substance
If conventional weight loss methods are used, then body weight is reduced, but skeletal muscle mass is lost
Solution Approach 1:
The patent employs uncouplers with selective tissue distribution that preferentially target adipose tissue over skeletal muscle. This selective action allows weight loss through fat oxidation while preserving muscle mass, addressing the core problem of muscle wasting during diet-induced weight loss
Solution Approach 2:
The patent introduces selective mitochondrial uncouplers as intermediaries that mediate energy expenditure specifically in adipose tissue. These compounds act as selective mediators between dietary restriction and energy expenditure, preventing the non-selective muscle breakdown that occurs with conventional caloric restriction
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces fat mass and preserves muscle mass, leading to significant improvements in metabolic health and a reduction in the risk of complications associated with obesity and metabolic disorders, all while minimizing adverse effects.
Implementation Method 1
Compound 1 leverages a mitochondrial uncoupling mechanism to increase substrate utilization. Using a new controlled and targeted approach, Compound 1 can increase mitochondrial proton leak, an ongoing process in the body that dissipates energy, and accounts for 20%-40% of daily calories.
Implementation Method 2
Compound 1 can increase mitochondrial proton leak, an ongoing process in the body that dissipates energy, and accounts for 20%-40% of daily calories.
Implementation Method 3
the administration of chemical uncouplers of mitochondria as a means to decrease fat deposits has been ascientific goal for many years. While there are several small molecules which uncouple mitochondrial oxidative phosphorylation, the most well known is 2,4-dinitrophenol (DNP).
Data Source
AI summary
The present disclosure provides a method of preserving skeletal muscle mass during weight loss.